Skip to main content

Spanish company buys out Peninsula 'young blood' company for $146M

The company first invested in Alkahest, which has six mid-stage clinical trials in progress, in 2015.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.